NovoCure Limited Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
NovoCure Limited (NVCR) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $104.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-07-23
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $104.00K, a 98.24% decline year-over-year.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$219.00K.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $513.00K.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $789.00K.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$651.00K.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$95.00K.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$2.22M.
- NovoCure Limited increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was -$94.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.00K 10-Q · filed 2026-07-23 | -$115.00K 10-Q · filed 2026-07-23 | $398.00K derived: sum of 3 quarters · filed 2026-07-23 | $1.19M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$219.00K 10-Q · filed 2026-04-30 | $294.00K derived: sum of 2 quarters · filed 2026-07-23 | $1.08M derived: sum of 3 quarters · filed 2026-07-23 | $7.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $513.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | $1.30M derived: sum of 2 quarters · filed 2026-07-23 | $7.22M derived: sum of 3 quarters · filed 2026-07-23 | $4.95M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $789.00K 10-Q · filed 2025-10-30 | $6.71M derived: sum of 2 quarters · filed 2026-07-23 | $4.44M 10-Q · filed 2025-10-30 | $3.73M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $5.92M 10-Q · filed 2026-07-23 | $3.65M 10-Q · filed 2026-07-23 | $2.94M derived: sum of 3 quarters · filed 2026-07-23 | $1.72M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | -$2.27M 10-Q · filed 2026-04-30 | -$2.98M derived: sum of 2 quarters · filed 2026-04-30 | -$4.20M derived: sum of 3 quarters · filed 2026-04-30 | -$4.54M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.92M derived: sum of 2 quarters · filed 2026-02-26 | -$2.27M derived: sum of 3 quarters · filed 2026-02-26 | -$651.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.21M 10-Q · filed 2025-10-30 | -$1.56M derived: sum of 2 quarters · filed 2025-10-30 | $60.00K 10-Q · filed 2025-10-30 | -$565.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$349.00K 10-Q · filed 2025-07-24 | $1.27M 10-Q · filed 2025-07-24 | $648.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.62M 10-Q · filed 2025-04-24 | $997.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.48M derived: sum of 3 quarters · filed 2026-02-26 | $2.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$145.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.02M derived: sum of 3 quarters · filed 2026-02-26 | -$95.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $480.00K 10-Q · filed 2024-10-30 | $1.65M derived: sum of 2 quarters · filed 2024-10-30 | $530.00K 10-Q · filed 2024-10-30 | -$864.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.17M 10-Q · filed 2024-07-25 | $50.00K 10-Q · filed 2024-07-25 | -$1.34M derived: sum of 3 quarters · filed 2025-02-27 | -$1.34M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.12M 10-Q · filed 2024-05-02 | -$2.51M derived: sum of 2 quarters · filed 2025-02-27 | -$2.51M derived: sum of 3 quarters · filed 2025-02-27 | -$3.12M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.39M derived: sum of 2 quarters · filed 2025-02-27 | -$2.00M derived: sum of 3 quarters · filed 2025-02-27 | -$2.22M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.00K 10-Q · filed 2023-10-26 | -$601.00K derived: sum of 2 quarters · filed 2023-10-26 | -$822.00K 10-Q · filed 2023-10-26 | -$916.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$602.00K 10-Q · filed 2023-07-27 | -$823.00K 10-Q · filed 2023-07-27 | -$917.00K derived: sum of 3 quarters · filed 2024-02-22 | -$917.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$221.00K 10-Q · filed 2023-05-04 | -$315.00K derived: sum of 2 quarters · filed 2024-02-22 | -$315.00K derived: sum of 3 quarters · filed 2024-02-22 | -$315.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$94.00K derived: sum of 2 quarters · filed 2024-02-22 | -$94.00K derived: sum of 3 quarters · filed 2024-02-22 | -$94.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $0.00 10-Q · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |